IFPMA members commit to accelerate their effort to use their skills, technology and resources to bring safe, effective diagnostics, treatments and vaccines to patients around the world. Visit IFPMA COVID-19 Hub.
#TeamVaccines campaign
The world doesn’t just need COVID-19 vaccines. We need people around the world to feel confident in getting them, when it’s their turn. This campaign is an opportunity for all of us to help spread confidence and trust in the vaccines! Join #TeamVaccines now!
#TeamVaccines
COVID-19 GLOBAL BIOPHARMA CEO / TOP EXECS VIRTUAL PRESS BRIEFINGS
Videos
Watch More
Africa Young Innovators for Health Award
The first edition of the Africa Young Innovators for Health Award aims to promote innovative solutions dedicated to support, equip, protect and train healthcare professionals
Visit the website
COVID-19
IFPMA members commit to accelerate their effort to use their skills, technology and resources to bring safe, effective diagnostics, treatments and vaccines to patients around the world. Visit IFPMA COVID-19 Hub.
Read More
resources
Position Papers
Call to Action On Routine and Life-Course Immunization in the Context of the COVID-19 Pandemic
Life-course immunization can contribute to healthier, more productive, and longer lives, which enhances the sustainability of healthcare systems
Read More
The African Medicines Agency
AMA has the unique opportunity to become one of the most efficient and modern regulatory systems in the world.
Read More
AMR Action Fund
More than 20 leading pharmaceutical companies launched a ground-breaking collective venture - the AMR Action Fund - to bridge the current gap in funding for the development of new antibiotics
Read More
IFPMA Code of Practice eLearning
Our Code of Practice has evolved over time and it promotes a culture grounded on values, principles and decisions based on good judgement. You can take our new eLearning here!
Start training here
Previous
Next
IFPMA in Brief
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Tackling Global health challenges
The research-based biopharmaceutical industry is proud to be playing its part in the quest to find effective and sustainable solutions to today’s most pressing health concerns.
Read More
Boosting Innovation and Access
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Read More
Ethics and Business Integrity
The healthcare community and the public must be confident that research-based biopharmaceutical industry and their employees, wherever they operate, communicate and act in an ethical and professional manner.
Read More
Inventing Medicines and Vaccines
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
Read More
Previous
Next
FEATURED RESOURCES : News Releases
19 March 2020, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the world’s leading biopharmaceutical companies, today confirmed that having already mobilized on an unprecedented scale to respond to the COVID-19 pandemic, they commit to do more. The biopharmaceutical industry commits to accelerate its effort to...
Read More
Join IFPMA
Our membership has three levels tailored to meet specific needs. Full Members have to be R&D-based pharmaceutical companies or national associations whose membership includes innovative pharmaceutical companies; Associate Members of R&D-based pharmaceutical companies and national associations whose permanent staff numbers are less than five, and Affiliate Members that are organizations, associations, companies and institutions who are supportive of the R&D-based
LEARN MORE
Our Blog
25 Feb 2021
By James Anderson
Antibiotics have transformed healthcare. But today, the ubiquitous use of these live-saving drugs has led to the development of antibiotic-resistant bacteria. Once-treatable diseases like common infections of the bloodstream, urinary or respiratory tracts are becoming more difficult to treat using these tools. Combating drug resistance means facing a silent pandemic that could dwarf the impact COVID-19 has had on health systems and economies around the...
Read More
23 Feb 2021
By Thomas B. Cueni
This blog was originally posted on Pharma Boardroom on 23 February 2021 The story of COVID-19 vaccines is one of incredible collaboration. Never before has there been such an effort on a mass scale to solve a global health crisis. We've seen a decade of normal vaccine development compressed into just ten months. From the outset of the pandemic, our industry committed to do all...
Read More
22 Dec 2020
By Thomas B. Cueni
This oped was originally published on Media Planet Vaccine Awareness Campaign on 22 December 2020 Vaccines are one of the most cost effective interventions we have to safeguard public health and yet during this pandemic we have seen a decrease in public confidence. The latest World Economic Forum/Ipsos survey found that the number of people willing to get a COVID-19 vaccine has dropped to 73%...
Read More
Previous
Next